VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 189 filers reported holding VERACYTE INC in Q3 2019. The put-call ratio across all filers is 1.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $578 | -12.4% | 25,872 | -0.2% | 0.03% | -6.1% |
| Q2 2023 | $660 | +6.5% | 25,915 | -6.8% | 0.03% | +17.9% |
| Q1 2023 | $620 | -5.8% | 27,792 | +0.3% | 0.03% | -12.5% |
| Q4 2022 | $658 | -99.9% | 27,713 | -0.2% | 0.03% | +45.5% |
| Q3 2022 | $462,000 | +6.7% | 27,757 | +27.6% | 0.02% | +15.8% |
| Q2 2022 | $433,000 | +13.4% | 21,758 | +56.8% | 0.02% | +26.7% |
| Q1 2022 | $382,000 | -33.2% | 13,875 | 0.0% | 0.02% | -16.7% |
| Q4 2021 | $572,000 | -16.3% | 13,875 | -5.6% | 0.02% | -18.2% |
| Q3 2021 | $683,000 | +11.8% | 14,700 | -3.7% | 0.02% | +10.0% |
| Q2 2021 | $611,000 | -25.3% | 15,267 | +0.2% | 0.02% | -31.0% |
| Q1 2021 | $818,000 | +24.5% | 15,235 | -35.2% | 0.03% | +93.3% |
| Q4 2019 | $657,000 | -52.5% | 23,500 | -59.2% | 0.02% | -51.6% |
| Q3 2019 | $1,383,000 | -16.9% | 57,600 | -1.4% | 0.03% | -18.4% |
| Q2 2019 | $1,665,000 | +13.8% | 58,400 | -0.2% | 0.04% | +26.7% |
| Q1 2019 | $1,463,000 | – | 58,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 123,030 | $2,920 | 3.08% |
| ARK Investment Management | 8,300,241 | $196,964,719 | 1.71% |
| EFG Asset Management (North America) Corp. | 291,328 | $7,018,091 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $4,746,000 | 1.36% |
| Granahan Investment Management | 1,763,266 | $41,842,302 | 1.28% |
| Nikko Asset Management Americas, Inc. | 3,064,445 | $72,596,702 | 1.05% |
| ArrowMark Colorado Holdings LLC | 2,789,670 | $66,198,869 | 0.79% |
| CLOUGH CAPITAL PARTNERS L P | 316,976 | $7,521,840 | 0.76% |
| Parkman Healthcare Partners LLC | 117,726 | $2,793,638 | 0.74% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 139,562 | $3,312 | 0.52% |